African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring neisseria gonorrhoeae and chlamydia trachomatis in the methods for improving reproductive health in Africa trial

Sexually Transmitted Diseases

Volumn 38, Issue 6, 2011, Pages 562-570

  Venkatesh, Kartik K ^a   Van Der Straten, Ariane ^b,c   Mayer, Kenneth H ^a   Blanchard, Kelly ^d   Ramjee, Gita ^e   Lurie, Mark N ^a   Chipato, Tsungai ^f   Padian, Nancy S ^b   De Bruyn, Guy ^g  

^a BROWN UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d IBIS REPRODUCTIVE HEALTH   (United States)

^e SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^f UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^g UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICA; ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; FEMALE; GONORRHEA; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; NONHUMAN; REPRODUCTIVE HEALTH;

ADULT; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; COHORT STUDIES; CONTRACEPTIVE DEVICES, FEMALE; FEMALE; GELS; GONORRHEA; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; MIDDLE AGED; NEISSERIA GONORRHOEAE; PREVALENCE; REPRODUCTIVE HEALTH; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES, BACTERIAL; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT; ZIMBABWE;

EID: 79957661127     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e31820a8c2c     Document Type: Article

References (41)

1. Laga MM, Kivuvu M, Malele B, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: Results from a cohort study. AIDS 1993; 7:95-102. (Pubitemid 23069039)
2. Grosskurth H, Gray R, Hayes R, et al. Control of sexually transmitted diseases for HIV-1 prevention: Understanding the implications of the Mwanza and Rakai trials. Lancet 2000; 355: 1981-1987. (Pubitemid 30326108)
3. Laga M, Alary M, Nzila N, et al. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet 1994; 344:246-248.
4. World Health Organization. Global prevalence and incidence of selected curable sexually transmitted infections, overviews and estimates. Available at: www.who.int/hiv/pub/sti/who-hiv-aids-2001.02.pdf. Accessed June 1, 2010.
5. Røttingen J, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: How much really is known? Sex Transm Dis 2001; 28:579-597. (Pubitemid 32937567)
6. Kaul R, Kimani J, Nagelkerke NJ, et al; Kibera HIV Study Group. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: A randomized controlled trial. JAMA 2004; 291:2555-2562. (Pubitemid 38702773)
7. Watson-Jones D, Weiss HA, Rusizoka M, et al; HSV trial team; Steering and Data Monitoring Committees. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358:1560-1571. (Pubitemid 351519816)
8. Fleming D, Wasserheit JN. From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17. (Pubitemid 29117474)
9. Ghys P, Fransen K, Diallo MO, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Côte d'Ivoire. AIDS 1997; 11:F85-F93. (Pubitemid 27421168)
10. Kaul R, Kimani J, Nagelkerke NJ, et al. Risk factors for genital ulcerations in Kenyan sex workers. The role of human immunodeficiency virus type 1 infection. Sex Transm Dis 1997; 24:387-392. (Pubitemid 27452564)
11. Cohen M, Hoffman IF, Royce RA, et al; AIDSCAP Malawi Research Group. Reduction of concentration of HIV-1 in semen after treatment of urethritis: Implications for prevention of sexual transmission of HIV-1. Lancet 1997; 349:1868-1873. (Pubitemid 27270120)
12. Cates WJ, Wasserheit JN. Genital chlamydial infections: Epidemiology and reproductive sequelae. Am J Obstet Gynecol 1991; 164(6 pt 2):1771-1781.
13. Sexton J, Garnett G, Røttingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis 2005; 32:351-357. (Pubitemid 40727179)
14. Plummer F, Simonsen JN, Chubb H, et al. Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection. J Clin Invest 1989; 83:1472-1476. (Pubitemid 19124099)
15. McClelland R, Lavreys L, Katingima C, et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: A 10-year prospective study. J Infect Dis 2005; 191:333-338. (Pubitemid 40139757)
16. Padian N, Van Der Straten A, Ramjee G, et al; MIRA Team. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: A randomised controlled trial. Lancet 2007; 370:251-261. (Pubitemid 47069513)
17. Ramjee G, Van Der Straten A, Chipato T, et al; MIRA team. The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: Results of a randomized controlled trial. PLoS One 2008; 3:e3488.
18. Cleves M, Gould WW, Gutierrez RG, et al. An Introduction to Survival Analysis Using STATA, 2nd ed. College Station, TX: Stata Press, 2008.
19. Van Der Pol B, Martin DH, Schachter J, et al. Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol 2001; 39:3092-3098. (Pubitemid 32830299)
20. Johnson L, Lewis DA. The effect of genital tract infections on HIV-1 shedding in the genital tract: A systematic review and meta-analysis. Sex Transm Dis 2008; 35:946-959.
21. Kaul R, Nagelkerke NJ, Kimani J, et al; Kibera HIV Study Group. Prevalent herpes simplex virus type 2 infection is associated with altered vaginal flora and an increased susceptibility to multiple sexually transmitted infections. J Infect Dis 2007; 196:1692-1697. (Pubitemid 351411969)
22. McFarland W, Gwanzura L, Bassett MT, et al. Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis 1999; 180:1459-1465. (Pubitemid 29506446)
23. Rotchford K, Strum AW, Wilkinson D. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital-tract secretions: Systematic review and data synthesis. Sex Transm Dis 2000; 27:243-248. (Pubitemid 30252413)
24. Greenblatt R, Bacchetti P, Barkan S, et al. Lower genital tract infections among HIV-infected and high-risk uninfected women: Findings of the Women's Interagency HIV Study (WIHS). Sex Transm Dis 1999; 26:143-151. (Pubitemid 29122737)
25. Ghys P, Diallo MO, Ettiègne-Traoré V, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis 1995; 172:1371-1374.
26. Kreiss J, Willerford DM, Hensel M, et al. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis 1994; 170:1597-1601. (Pubitemid 24369926)
27. Rebbapragada A, Wachihi C, Pettengell C, et al. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2007; 21:589-598.
28. Muenzner P, Naumann M, Meyer TF, et al. Pathogenic Neisseria trigger expansion of their carcinoembryonic antigen-related cellular adhesion molecule 1 (CEACAM1; previously CD66a) receptor on primary endothelial cells by activating the immediate early response transcription factor, nuclear factor-kappaB. J Biol Chem 2001; 276:24331-24340.
29. Mayer K, Venkatesh KK. Co-prevalent and synergistic effects of HIV, sexually transmitted diseases, and genital tract inflammation on pathogen transmission and acquisition. Am J Reprod Immunol. In press.
30. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Morb Mortal Wkly Rep 2003; 52:1-17.
31. Mostad S, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350:922-927. (Pubitemid 27420529)
32. McClelland R, Wang CC, Mandaliya K, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001; 15:105-110. (Pubitemid 32055785)
33. Wang C, McClelland RS, Reilly M, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001; 183:1017-1022. (Pubitemid 32230948)
34. Kaul R, Rowland-Jones SL, Gillespie G, et al. Gonococcal cervicitis is associated with reduced systemic CD8- T cell responses in human immunodeficiency virus type 1-infected and exposed, uninfected sex workers. J Infect Dis 2002; 185:1525-1529.
35. World Health Organization. Guidelines for the Management of Sexually Transmitted Infections. Geneva, Switzerland: World Health Organization, 2001.
36. Venkatesh K, Van Der Straten A, Cheng H, et al. The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the MIRA study. Int J STD AIDS. In press.
37. Cottingham J, Hunter D. Chlamydia trachomatis and oral contraceptive use: A qualitative review. Genitourin Med 1992; 68: 209-216.
38. Lavreys L, Chohan V, Overbaugh J, et al. Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS 2004; 18:2179-2184. (Pubitemid 39463683)
39. Mavedzenge SN, Pol BV, Cheng H, et al. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis 2010; 37:460-466.
40. Schroder K, Carey MP, Vanable PA. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med 2003; 26:104-123. (Pubitemid 37271597)
41. Ward H, Rönn M. Contribution of sexually transmitted infections to the sexual transmission of HIV. Curr Opin HIV AIDS 2010; 5:305-310.